Know Cancer

forgot password

Communicating a Cancer Diagnosis: Current Methods and Their Effects

18 Years
Not Enrolling
Behavior, Cancer

Thank you

Trial Information

Communicating a Cancer Diagnosis: Current Methods and Their Effects


- The goals of the study are to identify how a patient with a diagnosis of cancer is
informed of their condition and to illuminate the way in which this information exchange


To distinguish, identify and determine:

- If the method by which a patient is informed of a diagnosis of cancer is associated
with their level of satisfaction with that method of being informed

- Who tells the patient of their condition

- The methods used to inform a patient of their condition

- Prognostic indicators of high satisfaction within the diagnostic consult


- Patients currently enrolled or being screened for enrollment for a phase I, II or III
clinical trial at the National Cancer Institutes clinic center- specifically, within
the following branch clinics: Medical Oncology, Metabolism, Surgery and Neuro-Oncology.

- Patient must be 18 years or older and be willing to participate in the study.


- Primary methodological practice is a self-administered questionnaire.

- Questionnaire to be completed by patient on same day that it is administered at NCI.

Inclusion Criteria


1. Age greater than or equal to 18 years.

2. A patient diagnosed with cancer who is either currently enrolled in a protocol and
receiving treatment or has come to NCI for consult and potential enrollment in a

3. Ability to follow basic verbal instructions as observed by either an investigator of
the study or as reported by a member of the patient's primary clinical team.

4. Patient must comprehend English, verbal and written, to be determined by the
investigator distributing the questionnaire.

-Patients with a hearing and/or visual impairment will be eligible to participate in
the study if they so choose. Appropriate accommodations will be made.

5. Signed informed consent form.


1. Patients that have cognitive impairments, such as mental challenges/retardation due
to a congenital or developmental anomaly.

a. Subjects with cognitive impairments are ineligible to participate in the study due
to comprehension inabilities.

2. Patients who have developed dementia as a result of their disease or from an
unspecified source are not eligible for participation due to both memory and overall
cognitive deficits.

3. Patients that have multiple concurrent cancers are excluded from participation in
this study.

Type of Study:


Study Design:



United States: Federal Government

Study ID:




Start Date:

April 2008

Completion Date:

July 2009

Related Keywords:

  • Behavior
  • Cancer
  • Communicating a Diagnosis
  • Cancer Diagnosis
  • Recurrence of Cancer
  • Initial Cancer Diagnosis



National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland  20892